Expansion Of Specific Lymphocytes With 4Cell® Nutri-T Xeno-Free And Serum-Free Medium
By Michal J. Besser, Katya Israel, Dragoslav Zikich, Sharon Daniliuc, Mira Genser Nir, Marina Teverovski, Adi Aizenshtat, Julia Hupfeld, Kyle Ritchie, Kat Kozyrytska, Anna Quach, Alexander Tappe, David Fiorentini, and Maya Fuerstenau-Sharp
Autologous CAR-T therapy success hinges on the robust expansion of specific subpopulations of patient-derived immune cells. Successful expansion is reliant on the use of media tailored for this specific purpose, ideally devoid of serum as it introduces variability that can lead to a lack of reproducibility and increased patient risk. This application note elucidates the advantages of a xeno- and serum-free medium for the targeted expansion of cell subpopulations without the addition of serum. This medium enables robust manufacturing processes, facilitates process control, and demonstrates exceptional performance in terms of fold expansion.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.